🔎 Trials Near Me

Home › Sarcoma ng Malambot na Tisyu › North Carolina

Pag-aaral pangklinika para sa Sarcoma ng Malambot na Tisyu sa North Carolina

13 pag-aaral para sa Sarcoma ng Malambot na Tisyu ang naghahanap ng mga kalahok sa mga site sa North Carolina.

Mga Lungsod sa North Carolina

Opisyal na teksto ng pag-aaral (English)

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Novant Health Cancer Institute - Kernersville, Kernersville
  • Novant Health Cancer Institute - Mount Airy, Mount Airy
  • Novant Health Forsyth Medical Center, Winston-Salem
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • AdventHealth Infusion Center Asheville, Asheville
  • Southeastern Medical Oncology Center-Clinton, Clinton
  • AdventHealth Infusion Center Haywood, Clyde
  • at 6 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

DESTINY-PANTUMOUR04

  • Research Site, Durham
  • Research Site, Wilson
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  • Levine Children's Hospital- Pediatric Neuro-Oncology, Charlotte
Nagre-recruitPhase 1/2
Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

GRID Therapy for Extremity Soft Tissue Sarcoma

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06073067

A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)

  • Duke Cancer Center, Durham
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06263231

Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma

  • Levine Cancer Institute, Charlotte
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT07291297

LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients

  • Levine Cancer Institute, Charlotte
  • Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06958107

Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?

  • Duke University, Durham
Nagre-recruitObservasyonal na pag-aaral
Edad 16 hanggang 75 · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT03261544

Integrated Cancer Repository for Cancer Research

  • Cape Fear Valley Health System, Fayetteville
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699

Exercise and Soft Tissue Sarcoma

  • Duke University, Durham
Nagre-recruit
Edad 18 hanggang 85 · Lahat ng kasarian · Na-update Abr 8, 2026 · NCT04921917

Disease Outcomes and Toxicities in Patients With Gastrointestinal and Sarcomatous Malignancies

  • University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Mar 30, 2026 · NCT05743426

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

  • Duke Cancer Institute, Durham
Nagre-recruit
Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Ene 28, 2026 · NCT06371768

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.